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ABSTRACT  
Glutathione is an important cellular antioxidant.  This study evaluated the association of 
diet intake and brain glutathione levels in living subjects.  A Block food frequency 
questionnaire (FFQ) and Magnetic Resonance Imaging  were used to measure dietary 
intake and brain glutathione levels for two groups of elderly subjects, one group with early 
stage Alzheimer's disease (n=23) and a second age-matched control group (n=21).  The 
average age was 73.4 ± 5.5 years and 63% male. There was no significant difference in 
brain glutathione levels between the two groups.  Stepwise regression analysis of diet 
intake and brain glutathione levels showed a direct relationship between specific nutrients: 
positive relationship with potato and dairy servings, cysteine, retinol and vitamin B12; 
negative relationships with meat servings, riboflavin, vitamin D and calcium supplements. 
This study investigating diet and brain glutathione levels in living subjects support 
previous study results showing specific nutrients are associated with brain glutathione 
levels.   
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Chapter 1: Introduction 
 
Justification 
     Glutathione is a tripeptide made from nonessential dietary amino acids:  
glutamate, cysteine and glycine and plays many important roles in the body.  A primary 
role for glutathione is acting as a potent cellular antioxidant to prevent oxidative damage 
from reactive oxygen species (ROS) released during normal metabolism and increased 
reactive oxygen species production under stress conditions (1).  Glutathione is also a 
storage form for cysteine (1).  Cysteine is the rate limiting substrate amino acid and is 
found oxidized to cystine outside the cell (1).  Cells vary in their capacity to use cystine as a 
substrate for glutathione synthesis and many cell types, including brain neurons, rely on 
extracellular glutathione to supply substrate cysteine (1).   
  Dietary intakes of amino acids influence tissue levels of glutathione.  Studies 
investigating the effect of protein intake on glutathione levels under oxidative stress 
conditions like inflammation, infection, malnutrition and ageing show improved 
glutathione status (2-8).  Intakes of other nutrients also influence glutathione levels.  
Studies have shown increased intakes of saturated fat and omega 6 fatty acids reduce 
glutathione levels in neurons while intakes of omega 3 and unsaturated fatty acids increase 
glutathione levels in neurons (9-12).   
 Other research suggests the ageing process is associated with declining levels of 
glutathione and increasing levels of oxidative stress (1,13-15).  Studies investigating 
progression of mild cognitive impairment and early Alzheimer’s disease show evidence of 
increasing oxidative damage with disease progression (16).   
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     Researchers have documented a relationship between dietary intake and 
glutathione levels in different human tissues (2-12).  Research also suggests a relationship 
between glutathione levels and oxidative damage in different tissues (1, 13-15).  Studies 
investigating glutathione levels and cognitive decline associated with Alzheimer’s disease 
have shown serum levels of glutathione do correlate with disease progression (16,17).  
Further, brain cellular glutathione levels in postmortem subjects is also indicative for 
cognitive decline status (16,17).    
 There has been very little research investigating brain glutathione levels, oxidative 
damage and progression of cognitive decline in living patients.  Research is needed to 
establish the relationship between dietary intake, brain cellular glutathione levels and 
progression of cognitive decline in living subjects.  Previous research indicates brain 
glutathione levels are predictive for cognitive decline status and diet can improve 
glutathione levels in many tissues under stress conditions (2-8,16,17).  The correlation of 
brain glutathione levels with both diet and cognitive decline in living subjects could offer a 
new way to identify cognitive decline in early stages and potential to use dietary intake to 
prevent, treat or slow disease progression.       
 Dietary intake could affect brain levels of glutathione, a powerful cellular 
antioxidant, which may prevent oxidative damage associated with ageing, cognitive decline 
and the progression of Alzheimer’s disease. 
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Statement of Purpose 
 The purpose of this study is to determine the relationship between dietary intake 
and brain glutathione levels in elderly individuals with and without cognitive decline.   
 
Research Questions 
Primary Question 
1. Does dietary intake influence brain glutathione concentrations within elderly individuals 
with early Alzheimer’s disease? 
Secondary Question 
2. Do brain levels of glutathione differ between groups of individuals with and without 
Alzheimer’s Disease?  
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Chapter 2: Review of Literature 
 
Brain Antioxidant Requirements 
 Human brain cells make up a very small portion of our total body weight but use 
20% of the body’s total oxygen intake (1,17).  High levels of oxygen used for oxidative 
phosphorylation by brain mitochondria lead to increased generation of superoxide, a 
reactive oxygen species (1,17,18).   Research predicts up to 4% of the oxygen used in brain 
tissue is converted to superoxide (1,18).  Superoxide dismutase converts superoxide to 
hydrogen peroxide which is converted to water and oxygen by glutathione, glutathione 
peroxidase and catalase (1,9,17)(appendix A&B).  The activity of these enzymes is lower in 
the brain than in other organs, including the liver or kidney (1).  Lower levels of super 
oxide dismutase, catalase and glutathione peroxidase activity coupled with increased levels 
of reactive oxygen species increase the potential for oxidative damage to the high lipid 
content of the brain (1,4,15,17).  Brain levels of antioxidants are also important because 
some areas of the brain contain increased levels of iron (14,15,17,19,20).   Brain tissues 
under oxidative stress can release iron creating hydroxyl radicals which accelerate tissue 
damage (14,15,17,19,20).  Antioxidant levels are also important because the brain 
synthesizes large amounts of nitric oxide (1).  Nitric oxide has many functions in the brain 
including acting as a neural transmitter (1).  Under oxidative stress, nitric oxide can react 
with superoxide to produce peroxynitrate, further increasing oxidative damage (1,9,17).  
Brain cells also have varied capacity to use antioxidant substrate amino acids (1,21).   
Supply of substrate amino acids is important because brain tissues have a limited capacity 
to use methionine as a precursor to cysteine and rely heavily on extracellular sources of 
cystine and glutathione to supply the rate limiting substrate cysteine (1,21). 
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Glutathione:  Roles and Functions 
 As an antioxidant, glutathione acts directly on free radicals and reactive oxygen 
species and is oxidized to glutathione disulfide which is recycled by glutathione reductase 
back to glutathione (1,4,9,12,17,22).  Glutathione acts indirectly with the enzymes 
glutathione peroxidase and glutathione-S-transferase (1,9).  Glutathione peroxidase reacts 
with glutathione and hydrogen peroxide reducing it to water and oxygen while forming 
glutathione disulfide, which is then recycled back to glutathione (1,4,9).  Glutathione-S-
transferase reacts with glutathione on electrophilic compounds and xenobiotics to detoxify 
cells by forming disulfides which are transported out of the cell (1,4,9,23).  Glutathione 
provides a storage and transport mechanism for cysteine which is most often oxidized to 
cystine outside the cell (1,4,9,17).  Glutathione forms S-nitrosoglutathione with nitric oxide 
in the brain to control oxidative stress (1,4,24).  Glutathione prevents oxidative stress from 
damaging proteins by reversibly binding to proteins preventing oxidation (1).  Glutathione 
is also important in recycling other antioxidants, cell growth and immune functions 
(1,4,9,14,25,26).  
 
Cellular Regulation and Synthesis of Glutathione 
 Glutathione levels are regulated by the availability of the substrate amino acids and 
enzymes γ-glutamylcγsteine synthetase (γ-GCS) and glutathione synthetase (GS) (14,27).   
γ-GCS is the rate limiting enzyme for synthesis of glutathione (14,27).  Oxidants generally 
increase synthesis of γ-GCS while low protein, phosphorylation and nitrosation of γ-GCS 
decrease synthesis (9,10,27).   
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Glutathione levels are controlled by feedback of glutathione which competes with 
glutamate in binding to γ-GCS in the first step of glutathione synthesis (9,27).  High levels  
of glutathione inhibit synthesis while low levels of glutathione increase synthesis of 
glutathione (14).   
      Cysteine is the rate limiting substrate amino acid (9,27).  Cellular levels of cysteine 
are much lower than levels of glutamate or glycine (27).  Cysteine is a nonessential amino 
acid which becomes conditionally essential under stress conditions (9,27).  Outside the cell, 
cysteine is primarily found oxidized as cystine (9).  Brain cells can differ in their capacity to 
transport cystine (1).  Astroglial cells use both cysteine and cystine in glutathione synthesis 
while neurons can only use cysteine (1).  Cells without a transport mechanism for cystine 
rely on extracellular glutathione to serve as a source for cysteine in glutathione synthesis 
(1,17).  Brain cells with cystine transport system xc- exchange cystine (imported) for 
glutamate (exported) (1,17).  High levels of extracellular glutamine associated with disease 
conditions can limit this transport mechanism (1.6,9,27,28).   
 
Cellular Glutathione Levels 
 Cellular glutathione levels normally reflect a balance between synthesis and loss.  
Synthesis is based on the activity of γ-GCS, the supply of amino acid substrates and 
glutathione’s negative feedback on γ-GCS (27).  Balance is dependent on regeneration of 
glutathione from glutathione disulfide by glutathione reductase which maintains cellular 
glutathione levels (14).  Most cells also release or transport glutathione out of the cell 
leading to reduced cellular levels (27,29).   
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Glutathione levels are also affected by cellular reactions leading to loss.  Cellular levels of 
glutathione can decrease with increased levels of glutathione disulfide related to high 
levels of oxidative stress (27).  High levels of glutathione disulfide can lead to its transport 
out of the cell, lowering the glutathione pool (17,27,30).  Glutathione-S-transferase and 
glutathione act on electrophilic compounds and xenobiotics to detoxify cells (1,4,9,23).  
Conjugates formed using glutathione-S-transferase result in conversion to mercapturic acid 
which is excreted from the body, thus lowering glutathione levels (17,27).   
 
Brain Tissue Glutathione Levels 
 Brain levels of glutathione can vary based on cell type (15,17).  Astrocytes (glial 
cells) contain most brain glutathione and provide the glutathione substrate reservoir for 
cysteine, which is required for neural glutathione synthesis (1,31,32,33).  Neurons cannot 
transport extracellular cystine and rely upon glutathione released from astrocytes for 
synthesis of neural glutathione (1,32,33).   Neurons also contain lower levels of glutathione 
compared to astrocytes but contain higher levels of other antioxidants including ascorbate 
(17,27,30).  
 
Diet and Glutathione Levels 
 Studies investigating the effect of dietary protein and specific amino acid intakes 
show improved glutathione levels in study participants under oxidative stress conditions 
(2-8,14,34).  Four studies (1,35-37) investigated the potential of whey protein to increase 
cellular glutathione levels.   
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Whey protein increased glutathione levels in the heart and liver of ageing mice along with 
improving longevity (35).  Whey protein isolate was shown to improve glutathione levels in 
human prostate epithelial cells (1).  Commercial whey protein products Immunocal and 
Protectamin improved plasma glutathione levels in HIV patients (36,37).  Researchers 
believe whey protein and whey protein supplements, which contain high levels of cysteine, 
improve glutathione levels by removing the substrate rate limiting step in glutathione 
synthesis (2,8,35-37).  Supplementation of N-acetylcysteine (NAC) also works like whey 
protein to provide a source for cysteine.  NAC was shown to increase glutathione levels 
under stress conditions in the erythrocytes of malnourished children and in prostate 
epithelial cells (2,8).     
     New research is associating long term dietary intakes, and nutrition related 
conditions like diabetes, with increased risk for neurodegenerative diseases (38,49).  Two 
studies concluded type II diabetes substantially increases risk for developing Alzheimer’s 
disease (AD) (38,39).  The mechanism linking type II diabetes to AD is related to control of 
blood sugar and high carbohydrate, low fat diets (38).  High levels of glucose or fructose 
lead to formation of advanced glycation end products (AGE) (38).  AGE damage to LDL and 
LDL receptor proteins prevent astrocytes from receiving LDL lipids and cholesterol (38).  
Because astrocytes supply fats and cholesterol to neurons both types of cells become 
depleted disrupting proper neural function (38).  Researchers propose astrocytes then 
increase cholesterol synthesis to meet neural demands (38).  This process requires higher 
energy production and over time increases the oxidative stress damage to astrocytes (38).  
Intakes of other nutrients also influence glutathione levels.   
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According to Wu et al. (9,12), “glucosamine, taurine, n-3 polyunsaturated fatty acids, 
phytoestrogens, polyphenols, carotenoids, and zinc” preserve glutathione levels while 
“high-fat diet, saturated long-chain fatty acids, low density lipoproteins, linoleic acid, and 
iron” lower glutathione levels (9,12).  The first group maintains glutathione levels by 
decreasing nitric oxide production while the second group lowers glutathione levels by 
increasing nitric oxide production (9,12).  This is important for brain tissue because the 
brain produces large amounts of nitric oxide and increased production in neurons inhibits 
γ-GCS activity lowering glutathione levels (9,10,11).  
     New research suggests specific diets can be used to treat neurological disorders.  
Jarrett et al. (40) investigated the use of a ketogenic diet to prevent epileptic seizures.  
Researchers found the high fat, low CHO diet increased γ-GCS activity improving brain 
mitochondria glutathione levels in rats (40).  The ketogenic diet also helped improve 
mitochondrial levels of the antioxidant lipoic acid (40).  The ketogentic diet improved these 
antioxidant levels while decreasing levels of hydrogen peroxide produced by the 
mitochondria (40).  The study concluded the improved redox state of the brain 
mitochondria is the mechanism by which the ketogenic diet helps control epileptic seizures 
(40).  Based on this research, dietary changes to improve glutathione levels may be 
important in treating neurological disorders (40).     
 
Glutathione and Ageing 
 Evolutional physiology describes the ageing process based on the body’s ability to 
adapt and survive to reach reproductive age.   
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The body’s evolved defenses and response to disease, microbes, infection and virus using 
inflammatory/oxidative responses to cellular challenges may impact longevity in favor of 
reproductive survival (14).  The long term effect of oxidative stress, diet and lifestyle along 
with individual genetic regulation may result in the conditions associated with ageing 
(3,14).   
    Recent animal and human studies report glutathione levels or 
glutathione/glutathione disulfide ratios decline during the ageing process after the age of 
45 (14,41).  Reduced levels of glutathione may be related to decreased synthesis and/or 
increased oxidation (13).  Decreased synthesis can be related to substrate levels, enzyme 
activity, receptor activity, energy levels and genetic regulation, all of which can be effected 
by oxidative damage, nutrient intakes and disease conditions (1,13,27).   
 Studies reviewed here report improved glutathione levels or oxidative conditions in 
participants with stress conditions using dietary proteins; results indicate potential long 
term dietary intakes and/or deficiencies may be related to increasing oxidative conditions.  
The ageing process is generally associated with decreased lean muscle, lower levels of 
activity and lower energy requirements (42).  These changes in combination with an 
increasing oxidative state may contribute to oxidative dysfunction (42).   
 Studies investigating protein and safe amino acid levels associate specific sulfur 
amino acids with improvements in glutathione levels under stress conditions or low 
protein intakes (34,42,43).  A study investigating protein intakes and nitrogen balance in 
healthy adults found glutathione levels were reduced and oxidation increased when 
protein levels decreased (34).    
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The researchers reported increased oxidative stress during the period needed to re-
establish nitrogen balance may indicate protein or specific amino acid levels may not be 
sufficient to protect subjects under normal daily stress or stress associated with ageing or 
disease conditions (34).   These studies also reported general recommendations for 
increasing protein intakes and specific sulfur amino acids is complex because of the role 
they play in methylation reactions which include gene regulation (34,42). 
 
Glutathione and Alzheimer’s Disease 
     Oxidative damage in neural tissue has been associated with the ageing process, 
cognitive decline and Alzheimer’s disease (AD) (13,16).  Research shows ageing is 
associated with declining glutathione levels relative to increasing oxidation in the brain 
(1,13-16,19,44).  Increased oxidation and decreased levels of glutathione lead to increasing 
damage to brain tissues (1).  High levels of oxygen consumption in the brain lead to 
increased formation of superoxides (1).  Superoxides normally react with super oxide 
dismutase to form hydrogen peroxide which is acted on by glutathione peroxidase and 
catalase to produce water and oxygen (1,17).  Decreased levels of glutathione limit this 
conversion causing increased cellular levels of superoxide and hydrogen perxoide 
increasing oxidative stress (1).  
     The brain also synthesizes large amounts of nitric oxide (1,45,46).  Glutathione 
depletion allows superoxide to react with nitric oxide forming peroxynitrite (9,10,17)  
Formation of peroxynitrite leads to oxidation of cellular proteins and lipids (1).  
Peroxynitrite inhibits glutathione peroxidase and enzyme activity related to energy 
production (1,46).    
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Decreased energy production limits synthesis of glutathione by inactivating ATP dependent 
enzymes γ-GCS and GS reducing cellular glutathione levels (1,15,16,19,27,47).  
Peroxidation of lipids leads to conversion of PUFA’s to 4-hydroxynonenal (4-HNE) (1,48).  
4-HNE is a toxic aldehyde which increases the demand for glutathione-S-transferase and 
lowers glutathione levels when conjugates are formed and exported out of the cell 
(1,13,1,30).  Increasing levels of oxidative damage can also release iron from brain tissue 
leading to the lipid peroxidation associated with the β-amyloid protein in AD (15,16).  
Research investigating the earliest effects of oxidative damage propose damage to 
transcription factors for γ-GCS and to cellular transport and receptor proteins initiate the 
dysfunction and decline of the cellular redox state (1,2,9,14-17,27).    
 
Glutathione Levels and Oxidative Stress 
  The ageing process is thought to be associated with declining levels of glutathione 
and increasing levels of antioxidant stress (1,13-15).  Lang et al. (49) reported erythrocyte 
glutathione levels are reduced in participants with chronic disease associated with ageing 
but not in healthy ageing participants without disease (49).  Based on study findings  
erythrocyte glutathione levels may indicate level or progression of disease conditions (49).  
Data also suggest decreased levels of glutathione are related to a reduction in synthesis, not 
increased production of glutathione disulfide (49).   
     Research has shown brain tissue glutathione levels may indicate cellular oxidative 
stress status (16).  Antioxidant levels have been correlated with changes in cognitive status 
and progression of cognitive decline (16,44).   
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Ansari et al. (16) and Padurariu et al. (44) reported antioxidant levels, including 
glutathione, were indicative for cognitive status based on the Mini Mental State 
Examination (MMSE) (16,44).  The study’s compared levels of antioxidants to MMSE scores 
for study groups including: noncognitively impaired, mild cognitively impairment, mild 
Alzheimer’s disease and Alzheimer’s disease (16,44).  Both studies report a decline in 
glutathione levels is associated with the earliest stages of cognitive decline and 
corresponds with disease progression (16,44). 
 
Conclusion 
 The brain demands high levels of oxygen for energy production which increases 
levels of reactive oxygen species (1,17).  The high lipid content of the brain makes it highly 
susceptible to oxidative damage (1,17).  Glutathione is protective against reactive oxygen 
species and under normal conditions, levels are regulated by the demand for antioxidants 
(9,14,27).  Previous research has shown glutathione levels decline after reaching maturity 
as a part of the ageing process (14,41).  Glutathione levels are thought to decline due to 
decreased synthesis or increased levels of oxidants (14,41).  New research suggests 
glutathione levels may or may not decline with ageing and decreases are associated with 
progression of conditions associated with ageing (49).  Research related to cognitive 
decline and Alzheimer’s disease show declining glutathione levels are associated with early 
stages of disease progression (16,44).  Based on these findings it is thought glutathione 
levels may be used to indicate progression of disease conditions (16,44).   
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Researchers investigating oxidative damage propose stress induced increases of oxidation 
damage the synthetic pathways associated with glutathione metabolism thus increasing 
cellular dysfunction (1,2,9,14-17,27).     
     Studies reviewed within this paper report glutathione levels in several different 
type cells under stress conditions in both human and animal subjects.  Results indicate the 
status of glutathione related to stress conditions and some report the effect of diet on those 
glutathione levels.  No studies reviewed assessed glutathione levels in brain tissues of 
living subjects.  Studies which investigated cognitive decline in living subjects have shown 
serum levels of antioxidants are correlated with disease progression (17).   
 Sneff et al. (38) reported subjects with type II diabetes are up to five times more 
likely to develop Alzheimer’s disease (38).  This also indicates overall status of glutathione 
may be associated with systemic oxidative stress contributing to progression of many 
conditions including cognitive decline.  Research investigating the association between 
dietary intakes and glutathione levels show under stress conditions diet can influence 
cellular levels.  Further, dietary intakes of whey protein and NAC are shown to improve 
cellular levels of glutathione in subjects under stress conditions (2-8).  Dietary intakes of 
fatty acids also are shown to influence glutathione levels via their effect on metabolism and 
nitric oxide production which can inhibit γ-GCS in neurons (6,9,40).   
 Currently, in the United States 4.5 million people have Alzheimer’s or related 
dementias (50).  The number of Americans with Alzheimer’s is increasing and could reach 
16 million by the year 2050 (50).  Alzheimer’s disease is now the sixth-leading killer and 
medical care for Alzheimer’s patients is estimated to cost more than a trillion dollars a year 
(50).  
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The United States government recently released a draft of its new Alzheimer’s plan which 
calls for new ways to treat and or prevent Alzheimer’s disease by 2025 (50).  
     Research has been conducted to show a relationship between dietary intake and 
glutathione levels in different human tissues (2-12).  Research has also shown a 
relationship between and glutathione levels and oxidative damage in different tissues 
(1,13-15).  Studies investigating glutathione levels and the cognitive decline associated 
with Alzheimer’s disease have shown serum levels of glutathione do correlate with disease 
progression (16,17).  Further, brain cellular glutathione levels in postmortem subjects is 
also indicative of cognitive decline status (16,17).   There are few studies investigating 
brain cell glutathione levels, oxidative damage and progression of cognitive decline in living 
patients.    
 Research is needed to establish the relationship between dietary intake, brain 
cellular glutathione levels and progression of cognitive decline in living subjects.  Previous 
research indicates glutathione levels are predictive for cognitive decline and diet intake can 
improve glutathione levels in many tissues under stress conditions (2-8, 16,17).  The 
correlation of brain glutathione levels with both diet and cognitive decline in living subjects 
could offer a new way to identify cognitive decline in early stages and a way to prevent or 
at least slow disease progression.    Research suggests increasing oxidative damage is 
associated with progression of cognitive decline and under stress conditions dietary intake 
can help to improve glutathione levels.  
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Chapter 3: Methods 
 
 
 
Overview 
 
 The purpose of this thesis is to determine the effect dietary intake has on brain 
glutathione levels which have been associated with the cognitive decline of Alzheimer’s 
disease.  This cross-sectional study collected data for dietary intake and brain glutathione 
levels in elderly people (n=44) with early  Alzheimer’s  (n=23), as well as, elderly 
individuals without Alzheimer’s (n=21).     
 
Sample 
 Study participants were recruited using University of Kansas Medical Center emails 
and fliers, the Grayhawk Registry and the KU Brain Aging Project Uniform Dataset Registry.  
To be eligible for this study participants  had to be between 60 and 85 years of age, 
education of more than ten years, no significant psychiatric disorders, ability to perform 
neuropsychological testing, and general good health. Participants with a clinical dementia 
rating of mild to very mild Alzheimer’s were required to have a study partner available to 
provide information about the participant’s daily activities.  Exclusion criteria were:  
presence of neurological disease with the exception of Alzheimer’s disease which affects 
cognition; diabetes mellitus; abnormal  vitamin B₁₂; rapid plasma regain or  thyroid 
function lab values; use of psychoactive medications; use of  specific antioxidant therapy or 
special dietary regimens and specific  MRI contraindications such as metal plates in their 
body.     
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Research Setting  
 The data were collected from subjects at the Hoglund Brain Imaging Center at the 
University of Kansas Medical Center.  Interested subjects from the Grayhawk Registry, the 
KU Brain Aging Project Uniform Dataset Registry and respondents from KUMC email and 
flyers were first screened by telephone to determine eligibility using self reported height, 
weight and brief medical history.  The Grayhawk Registry is a database of Kansas City area 
residents greater than 60 years of age who join the registry making them potential study 
participants for University of Kansas Medical Center research projects.  The Uniform 
Dataset Registry operated by the University of Kansas Alzheimer and Memory Program 
recruits age matched healthy and Alzheimer’s diagnosed study participants for aging and 
Alzheimer’s disease research.  Eligible subjects who passed the initial screening were 
screened for metal in their body following a MRI safety protocol.   
Ethics 
 The procedures for this thesis project were approved by the University of Kansas Medical 
Center Human Subjects Committee. All participates signed and received a consent form.  Study 
participants who completed the diet history questionnaire and the magnetic resonance scan 
will received fifty dollars for participation in the study.   
Data Collection 
 At the initial study visit diet research staff collected demographic information, 
anthropometric measurements and administered a food frequency questionnaire outlined 
in the instrumentation section below.   Upon completing the initial study visit, the 
participants returned approximately one week later for magnetic resonance testing (MRI).    
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Instrumentation 
On the initial study visit research staff conducted the following: 
Demographics Questionnaire  
 Demographic information (age, gender, race/ethnicity) were collected to 
characterize the sample population used in the study. 
Food Frequency Questionnaire  
The Block Food Frequency Questionnaire was used to estimate participants’ normal 
dietary intake over the last year (51-56).  This tool was originally developed by Gladis 
Block and has been validated and used in numerous research studies. (51-56).  Food 
frequency data are recommended for estimating dietary intake in elderly and Alzheimer’s 
participants who may suffer short term memory loss (51-56).  Participants completed the 
questionnaire and submitted it to a research dietitian to review for completeness. 
Individuals with early AD completed the questionnaire the help of their study partner.   
Magnetic Resonance Imaging  
 After the initial study visit, approximately one week later, participants returned to 
the University of Kansas Hoglund Brain Imaging Center for magnetic resonance imaging.  
The imaging took approximately one hour and assessed glutathione levels in the frontal 
and parietal areas of the brain using a chemical shift technique to detect glutathione. 
 
Analysis of Data 
Data from questionnaires, diet analysis, and brain imaging were entered into a data 
system managed using SAS (statistical analysis system).  Data were verified by dual entry 
and then exported for analysis.   Descriptive statistics and were used to describe the 
characteristics of the study population.   
 
25 
Descriptive statistics, t-test and a stepwise regression model were used for dietary intake 
and brain glutathione data analysis comparing the two groups separately and both groups 
combined.  Statistical significance was set at p < 0.05. 
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Chapter 4: Results 
 
 This section includes the results for the participant demographics, dietary intake, 
brain glutathione concentrations and correlations between diet and brain glutathione.    
Demographics 
Study participants (n=44) were recruited from University of Kansas Medical Center 
emails and fliers, the Grayhawk Registry and the KU Brain Aging Project Uniform Dataset 
Registry.  The participants were Caucasian males and females between 60 and 82 years of 
age.    The demographic data are depicted in Table 1.  
 
Table 1: Participant Characteristics 
 All 
(n = 44) 
Alzheimer’s 
(n = 23) 
Controls 
(n = 21) 
Age (years) 73.4 ± 5.5 73.7 ± 6.5 74.6 ± 6.1 
Gender (%) 63% Male 
36% Female 
69% Male 
30% Female 
57% Male 
42% Female 
 
Table 2 displays the brain glutathione concentrations in the participants.  There was no 
statistically significant difference in brain glutathione concentration between the 
Alzheimer’s and control group.   
Table 2: Brain Glutathione Concentration 
 All 
(n = 44) 
Alzheimer’s 
(n = 23) 
Controls 
(n = 21) 
Glutathione ( mol/g) 0.99 ± 0.154 0.966  ± 0.149  1.01 ± 0.159 
 (p = 0.31) 
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Dietary Intake   
The average energy intake of the study population was 1665 ± 776 kcal. The macronutrient 
distribution was 49 ± 7 % carbohydrate 15 ± 3 % protein and 34 ± 6 % fat. Table 3 lists the 
energy and selected nutrient intake of the population.  There was no difference in energy or 
macronutrient intake between the two groups.  Table 4 lists the micronutrient intake of the 
population and Table 5 displays the servings consumed from various food groups.  
 
Table 3.  Energy and selected nutrient intake for the population. 
Macronutrient 
All 
(n = 44) 
Alzheimer’s 
(n = 23) 
Controls 
(n = 21) 
p value 
Energy (kcal) 1665 ± 776 1697 ± 873 1518 ± 626 0.83 
Carbohydrate (g) 203 ± 78 197 ± 88 193 ± 84 0.97 
Protein (g) 64 ± 34 64 ± 39 59 ± 27 0.89 
Fat (g) 65 ± 43 70  ± 46 56 ± 25 0.74 
Fiber (g) 17 ± 8.6 16 ± 8.4 17 ± 9.6 0.92 
% Carbohydrate 49 ± 6.7 47 ± 5.8 50 ± 7.7 0.70 
% Protein  15 ± 2.9 14 ± 2.0 15 ± 3.5 0.75 
% Fat 34 ± 6.4 36 ± 6.9 33 ± 6.0 0.68 
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Table 4.  Micronutrient intake for the study population.  
Micronutrient 
All 
(n = 44) 
Alzheimer’s 
(n = 23) 
Controls 
(n = 21) 
Vitamin A ( g) 465 ± 268 410 ± 237 473 ± 265 
Vitamin C (mg) 100 ± 53 90 ± 53 117 ± 57 
Vitamin D ( g) 159 ± 108 132 ± 99 179 ± 114 
Vitamin E (mg) 7.2 ± 3.5 6.9 ± 3.5 7.3 ± 3.7 
Folic Acid ( g) 127 ± 83 138 ± 99 122 ± 80 
Folate (food) ( g) 271 ± 123 258 ± 129 284 ± 141 
Vitamin B12 ( g) 5.05 ± 2.62 4.9 ± 2.76 4.9 ± 2.45 
Calcium (mg) 851 ± 441 781 ± 505 884 ± 402 
Iron (mg) 12.82 ± 6.23 12.6 ± 6.34 12.4 ± 6.37 
Selenium ( g) 83 ± 46 83 ± 53 73 ± 34 
Zinc (mg) 10.2 ± 5.54 10.2 ± 6.28 9.5 ± 4.6 
 
Table 5.  Food Servings for Specific Food Groups. 
Food Group All 
(n = 44) 
Alzheimer’s 
(n = 23) 
Controls 
(n = 21) 
Fruit servings 1.5 ± 1.11 1.3 ± 1.10 1.7 ± 1.11 
Vegetable servings  3.1 ± 2.11 2.8 ± 2.10 3.2 ± 1.97 
Dairy servings 1.3 ± 1.21 1.1 ± 1.15  1.6± 1.16 
Grain servings  4.7 ± 2.90 4.8 ± 3.06 3.7 ± 2.02 
Meat servings 1.9 ± 1.33 2.1 ± 1.45 1.6 ± 1.09 
Fat servings 3.6 ± 1.58 3.7 ± 1.54 3.3± 1.63 
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There was no significant difference between groups in brain glutathione 
concentrations or dietary intake and thus the sample was combined for further analysis.  
Stepwise regression analysis results in Table 6 show the variables which were found to 
have a linear relationship with brain glutathione concentration in Alzheimer’s and control 
subjects.   The analysis found a positive association between brain glutathione levels and 
the following dietary intake variables:  percentage of servings vegetable potato, percentage 
of servings orange vegetables, dietary cysteine, dairy servings, dietary retinol and vitamin 
B12.  The analysis found a negative association between brain glutathione levels and the 
following dietary intake variables:  percentage of servings of meat, fish, poultry, dietary 
riboflavin, dietary vitamin D and supplemental calcium.  
Table 6.  Variables linearly related to brain glutathione concentration   
X Δ in GSH (y) per unit Δ of X p -  value  
Percentage Servings Meat, Fish, 
Poultry 
-0.050 .001 
Percentage Servings Vegetable 
Potato 
0.235 .001 
Dietary Cysteine (mg) 0.242 .001 
Dietary Riboflavin (mg) -0.196 .001 
Dairy Servings 0.159 .001 
Dietary Retinol (mcg) .00001 .001 
Dietary Vitamin B-12 (mcg) 0.047 .011 
Dietary Vitamin D (mcg) -0.001 .013 
Percentage Servings Orange 
Vegetable  
0.242 .031 
Supplemental Calcium (mg) -6.465 .053 
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Table 7 below displays the mean and standard deviation for the dietary variables 
found to be significant in the model and not included in the original descriptive dietary 
intake data (Tables 3-5).  
 
    Table 7.  Descriptive statistics for significant dependent variables.   
X Mean Std. Deviation 
Percentage Servings Meat, Fish, 
Poultry 
3.18 2.471 
Percentage Servings Vegetable 
Potato 
.23 .565 
Dietary Cysteine (mg) .80 .509 
Dietary Riboflavin (mg) 2.11 .868 
Dairy Servings 1.34 1.219 
Dietary Retinol (mcg) 465.20 268.376 
Dietary Vitamin B-12 (mcg) 5.05 2.623 
Dietary Vitamin D (mcg) 159.45 108.574 
Percentage Servings Orange 
Vegetable  
.02 .151 
Supplemental Calcium (mg) 434.23 488.168 
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Chapter 5: Discussion 
 The aim of this study was to determine the influence diet has on human brain levels 
of glutathione in vivo.  The results of this study show an association between certain 
nutrition components and brain levels of glutathione. 
These results confirm previous research showing dietary intake does influence 
glutathione levels in different tissues under disease/stress conditions.  In the current study 
dietary cysteine and dairy servings were positively correlated with brain glutathione levels 
in AD and control subjects. Dairy products, including whey protein, contain high levels of 
cysteine which have been shown to improve glutathione levels (1,35-37).  These results 
agree with previous study results showing whey protein and whey protein isolates 
improve glutathione levels in human and animal cells under stress conditions (1,35-37).  
Whey protein, whey protein isolates, dairy intake and dietary cysteine provide the rate 
limiting substrate amino acid cysteine for glutathione synthesis and other essential amino 
acids (2,8,35-37).   
 Meat servings were negatively correlated with brain glutathione levels in AD and 
control subjects.  Previous research has shown dietary intake of protein improved 
glutathione levels in different tissues under stress conditions and in malnourished children 
(2,8,34-37,42,43).  These studies investigated safe protein intake levels, nitrogen balance, 
whey protein and N-acetyl cysteine (NAC) supplements and found improvements in 
cellular glutathione levels under stress conditions.  The researchers concluded 
improvements were likely related to improving protein/amino acid intake, improving 
methionine intake and supplying substrate cysteine for glutathione synthesis (2, 8,35-37).  
The population in the current study differed as the participants were not malnourished.   
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The negative correlation shown in this study between meat servings and brain glutathione 
levels in AD and control subjects could be related to variables associated with meat 
consumption not accounted for in the diet history.  Variables associated with dietary meat 
intake could include: cooking of meat can affect the quality/amount of oxidized saturated 
and unsaturated fatty acids which have been shown to affect glutathione status, and meat 
quality including the amount of fat and the animals feed content can contribute to meat 
containing varying levels of omega 3, omega 6 and saturated fats which have been shown 
to affect glutathione levels (9,12).  Another potential variable contributing to the negative 
correlation between meat servings and brain glutathione levels may be that intake of 
protein does not necessarily represent absorption and utilization of the protein.  With the 
study population average age of 73 it is possible some study subjects had reduced ability to 
denature and absorb protein properly (57).  
 This study also found servings of vegetable/potato were positively correlated with 
brain glutathione levels in AD and control subjects (table 6).   The Block Food Frequency 
Questionnaire includes the following categories for potato/vegetable consumption:  French 
and home fries, hash browns, tater tots, yams, sweet potato, mashed potato, boiled and 
baked potato and potato salad.  Without knowing the nutritional content of the potato 
consumed in this category it is difficult to conclude how vegetable/potato servings 
contribute to improved brain glutathione levels.   
 Dietary Riboflavin/Vitamin B2 and Vitamin D intake were found to have an inverse 
relationship with brain glutathione levels in AD and control subjects.  Riboflavin is a 
coenzyme involved in oxidation reduction reactions and is important for maintaining 
cellular redox and for energy production (58). 
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It was unexpected to find the inverse association with brain glutathione because riboflavin 
is a coenzyme in reactions with glutathione reductase and glutathione peroxidase (58).  As 
a coenzyme in these reactions riboflavin helps to regenerate glutathione from glutathione 
disulfide, thus maintaining the cells glutathione pool (12).  Common dietary sources of 
riboflavin and Vitamin D are eggs, meats, milk, milk products, enriched grain products and 
cereals (58).  The inverse relationship shown between dietary riboflavin, Vitamin D and 
glutathione may be comparable to the negative correlation between meat intake and 
glutathione levels.  Because these nutrients are found in many animal products it is 
possible increased dietary levels represent a diet higher in fats including saturated fats, 
processed foods and lower in antioxidant intake.  Previous research has shown the 
potential for this type of diet to lower the cellular glutathione pool (9,12).     
 Dietary retinol and percentage servings orange vegetables were shown to have a 
positive linear relationship with brain glutathione levels (table 6).  While previous research 
has not shown a direct relationship between brain glutathione levels and orange vegetable 
intake, research has shown a diet rich in vegetable intake can provide phytonutrients and 
antioxidants which have been shown to preserve glutathione levels (5, 9,12).  It is also 
probable this type of diet, which contains higher vegetable intake, may also contain lower 
levels of animal products and damaged fats which have been shown to influence 
glutathione levels (9,12).  Dietary retinol comes largely from animal products.   
With the positive correlation shown between dairy servings and glutathione levels it is 
possible dairy products which contain and are fortified with Vitamin A share the positive 
linear relationship with brain glutathione levels.  
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 Dietary Vitamin B12 intake was shown to have a positive linear relationship with 
brain glutathione levels (table 6).  Research reviewed here has not previously shown this 
direct relationship between B12 and tissue glutathione or brain glutathione levels.  Proper 
cellular function is supported by the methylation pathway where Vitamin B12 is required 
to regenerate methionine from homocysteine.  Systemic glutathione levels are supported 
by methionine which can be used to supply the rate limiting substrate cysteine for 
glutathione synthesis.  While this mechanism is less active in the brain than in other 
tissues, support of the methyl cycle could increase brain glutathione levels when other 
tissues release glutathione into circulation (1,21).  Glutathione released from cells acts as a 
reservoir for cysteine which can be imported into brain astrocytes for glutathione 
synthesis (1,21).    
   
Brian Glutathione Levels 
 These study findings did not support previous research associating lower brain 
glutathione levels with the cognitive decline of Alzheimer’s Disease (16,44).  Previous 
research has shown cognitive decline to be associated with decreasing levels of brain 
antioxidants, including glutathione (16,44).  In this study brain levels of glutathione were 
not found significantly different when comparing controls to Alzheimer’s subjects.  This 
study investigated brain glutathione levels in subjects with a clinical dementia rating of 
very mild or mild Alzheimer’s disease.  It is possible significant differences in brain 
glutathione levels detectable by MRI in living subjects may become apparent with more 
disease progression.  The significance of the results found in this study is the association of 
brain levels of glutathione with dietary intake in living human subjects.   
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Conclusion 
 This study is one of the first to establish a relationship between dietary intake and 
brain glutathione levels in living subjects.  The correlation of brain glutathione levels with 
dietary intake in living subjects could offer a new way to identify cognitive decline in early 
stages and the potential for nutrition therapy to treat or slow disease progression.    
Research presented here indicates dietary intake does influence brain glutathione levels 
which have been shown in previous research to be associated with early stages and 
progression of cognitive decline.   
Limitation/Future Research 
 More research is needed to define the role specific nutrients and dietary variables 
play in the progression of oxidative damage and cognitive decline.  In this study a diet 
history questionnaire was used to establish the relationship nutrients have with measured 
brain glutathione levels in living subjects.  Diet history questionnaires are useful to identify 
eating patterns and types of foods eaten over periods of time.  More specific diet and 
nutrient intake data will be needed to establish nutritional mechanisms which might be 
useful for preventing, treating or controlling oxidative damage associated with aging and 
cognitive decline.  Other study limitations would include limited sample size and other 
possible confounding variables associated with development and progression of 
Alzheimer’s Disease which may play a role in diet and food preferences.  This study 
investigated glutathione levels in subjects with a CDR of very mild to mild Alzheimer’s in 
living subjects.  It is possible future research using MRI assessment of brain glutathione 
levels in living subjects may find significant differences in brain glutathione concentration 
levels where progression of cognitive decline is more advanced.   
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 Nutrition is shown here to be a primary environmental influence on brain 
glutathione levels.  Further research will be needed to identify other environmental 
variables involved in disease progression.  Inherited genetics and polymorphisms can 
influence metabolism and physiological function.  Further, new omic’s sciences are showing 
environmental influences of epigenetics, including nutrition, lifestyle and toxicity, can 
modify cellular processes and regulate genetic expression.   These environmental and 
genetic influences can affect specific nutrition requirements needed to optimize health in 
each individual over the lifespan and play a role in aging or disease progression.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
37 
References 
 
1. Aoyama, K., M. Watabe, and T. Nakaki, Regulation of neuronal glutathione synthesis.              
J Pharmacol Sci, 2008. 108(3): p. 227-238. 
2.  Kent, K.D.., W.J. Harper, and J.A. Bomser,  Effect of whey protein isolate on 
intracellular glutathione and oxidant-induced cell death in human prostate epithelial 
cells. Toxicol In Vitro, 2003. 17: p. 27-33.   
3. Marshall, K.,  Whey protein review, therapeutic applications of whey protein. Altern 
Med Rev, 2004. 9(2): p. 136-156.  
4.  Parodi, P.W., A role for milk proteins and their peptides in cancer prevention. Curr 
Pharm Des, 2007. 13(8): p. 813-828.  
5. Simopoulos, A.P., The Mediterranean Diets: What is so special about the diet of 
Greece?  The scientific evidence. J Nutr, 2001. 131(11 supp): p. 3065S-3073S. 
6. Lu, S.C., Regulation of hepatic glutathione synthesis: current concepts and 
controversies. FASEB J, 1999. 13: p. 1169-1183.  
7. Tateishi, N., T. Higashi, S. Shinya, A. Naruse, and Y. Sakamoto, Studies on the 
regulation of glutathione level in rat liver. J Biochem, 1974. 75(1): p. 93-103.   
8. Badaloo, A., M. Reid, T. Forrester, W.C. Heird, and F. Jahoor,  Cysteine 
supplementation improves the erythrocyte glutathione synthesis rate in children with 
severe edematous malnutrition. Am J Clin Nutr, 2002. 76: p. 646-652.   
9. Wu, G., Y.Z. Fang, S. Yang, J.R. Lupton, and N.D. Turner, Glutathione metabolism and 
its implications for health. J Nutr, 2004. 134: p. 489-492.   
10. Lu, S.C., Regulation of glutathione synthesis. Curr Top Cell Regul, 2000. 36: p. 95-116. 
 
38 
11.   Canals S., M. Jose´ Casarejos, S. de Bernardo, E. Rodriguez-Martin, and M. Angeles 
Mena, Nitric oxide triggers the toxicity due to glutathione depletion in midbrain 
cultures through 12-lipoxygenase. J Biol Chem, 2003. 278(24): p. 21542-21549.  
12.  Wu, G., and C.J. Meininger, Regulation of nitric oxide synthesis by dietary factors.  
Annu Rev Nutr, 2002. 22: p. 61-86.    
13.  Maher, P., The effects of stress and aging on glutathione metabolis. Ageing Res Rev, 
2005. 4(2): p. 288-314. 
14.  Townsend, D.M., K.D. Tew, and H. Tapiero, The importance of glutathione in human 
disease. Biomed Pharmacother, 2003. 57: p. 145-155.   
15.  Reid, M., and F. Jahoor, Glutathione in disease. Cur Opin Clin Nutr Metab Care, 2001. 
4(1): p. 65-71. 
16. Ansari, M.A., and S.W. Scheff,  Oxidative stress in the progression of Alzheimer disease 
in the frontal cortex.  J Neuropathol Exp Neurol, 2010. 69(2): p. 155-167.  
17.  Dringen, R., Metabolism and functions of glutathione in brain. Prog Neurobiol, 2000. 
62(6): p. 649-671. 
18.  Chance, B., H. Sies, and A. Boveris, Hydroperoxide metabolism in mammalian organs.  
Physiol Rev, 1979. 59(3): p. 527-605. 
19.  Andersen, J.K., Oxidative stress in neurodegeneration: Cause or consequence? Nat Med, 
2004. 10: p. S18-S25.   
20. Parodi, P.W., Dairy product consumption and the risk of breast cancer.  J Am Coll Nutr,       
2005. 24(6 Suppl): p. 556S-568S. 
 
39 
21.  Ishii, I., N. Akahoshi, X.N. Yu, et al., Murine cystathionine γ -lyase: Complete cDNA and 
genomic sequences, promoter activity, tissue distribution and developmental 
expression.  Biochem J,  2004. 381(pt 1): p. 113-123.   
22.  Fang, Y.Z., S. Yang, and G. Wu, Regulation of physiological systems by nutrients, free 
radicals, antioxidants, and nutrition.  Nutr, 2002. 18(10): p. 872-879. 
23.  Potter, J.D., Colorectal cancer:  Molecules and populations.  J Natl Cancer Inst, 1999. 
91(11): p. 916-932. 
24.  Rauhala, P., A.M. Lin, and C.C. Chiueh, Neuroprotection by s-nitrosoglutathione of 
brain dopamine neurons from oxidative stress.  FASEB J, 1998. 12(2): p. 165–173.   
25.  Poot,  M., H. Teubert, P.S. Rabinovitch, and T.J. Kavanagh, De novo synthesis of 
glutathione is required for both entry into and progression through the cell cycle.  J 
Cell Physiol, 1995. 163(3): p. 555-560. 
26.  Sagara, J., and N. Makino, Glutathione induces neuronal differentiation in rat bone 
marrow stromal cells.  Neurochem Res, 2008. 33(1): p. 16-21.   
27.  Griffith, O.W., Biologic and pharmacologic regulation of mammalian glutathione 
synthesis. Free Radic Biol Med, 1999.  27(9-10): p. 922-935.  
28.   Tapiero, H., G. Mathe, P. Couvreur, and K.D. Tew, Glutamine and glutamate.  Biomed 
Pharmacother, 2002. 56(9): p. 446-457. 
29.  Rana, S., and R. Dringen, Gap junction hemichannel-mediated release of glutathione 
from cultured rat astrocytes. Neurosci Lett, 2007. 415(1): p. 45-48.   
30.  Akerboom, T., and H. Sies, Glutathione transport and its significance in oxidative 
stress.  In: Vina J, ed.  Glutathione:  Metabolism and physiological functions. Boca 
Raton, FL: CRC Press, 1990: p. 45-55. 
 
40 
31.  Dringen, R., B. Pfeiffer, and B. Hamprecht, Synthesis of the antioxidant glutathione in 
neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione.  J 
Neurosci, 1999. 19(1/2): p. 562-569.  
32.  Kranich, O., B. Hamprecht, and R. Dringen, Different preferences in the utilization of 
amino acids for glutathione synthesis in cultured neurons and astroglial cells derived 
from rat brain.   
  Neurosci Lett, 1996. 219(3): p. 211-214. 
33.  Sagara, J.I., K. Miura, S. Bannai, Maintenance of neural glutathione by glial cells.            
J Neurochem, 1993. 61(5): p. 1672-1676.  
34.  Jackson, A.A., N.R. Gibson,  Y. Lu, and F. Jahoor, Synthesis of erythrocyte glutathione in 
healthy adults consuming the safe amount of dietary protein. Am J Clin Nutr, 2004. 
80(1): p. 101-107.  
35.  Bounous, G., F. Gervais, V. Amer, G. Batist, and P. Gold, The influence of dietary whey 
protein on tissue glutathione and the diseases of aging. Clin Invest Med, 1989. 12(6): 
p. 343-349.  
36.  Bounous, G., S. Baruchel, J. Falutz, and P. Gold,  Whey proteins as a food supplement in 
HIV-seropositive individuals. Clin Invest Med, 1993. 16(3): p. 204-209.     
37.  Micke, P., K.M. Beeh, J.F. Schlaak, and R. Buhl, Oral supplementation with whey 
proteins increases plasma glutathione levels of HIV-infected patients. Eur J Clin Invest, 
2001. 31(2):171-178. 
38.  Seneff, S., G. Wainwright, and L. Mascitelli, Nutrition and Alzheimer's disease: The 
detrimental role of a high carbohydrate diet. Eur J Intern Med, 2011. 22: p. 134-140. 
 
41 
39.  Fratiglioni, L., F. Mangialasche, and C. Qiu, Brain aging: Lessons from community 
studies. Nutr Rev, 2010. 68(2 supp): p. S119-S127.    
40.  Jarrett, S.G., J.B. Milder, L.P. Liang, and M. Patel, The ketogenic diet increases 
mitochondrial glutathione levels. J Neurochem, 2008. 106: p. 1044-1051. 
41.  Jones, D.P., V.C. Mody Jr, J.L. Carlson, M.J. Lunn, and P. Sternberg Jr, Redox analysis of 
human plasma allows separation of pro-oxidant events of aging from decline in 
antioxidant defenses. Free Radic Biol Med, 2002. 33(9): p. 1290-1300. 
42.  Fukagawa, N.K., and R.A. Galbraith, Advancing age and other factors influencing the 
balance between amino acid requirements and toxicity. J Nutr, 2004. 134: p. 1569S-
1574S.  
43.  Butterfield, D.A., C.B. Pocernich,and J. Drake, Elevated glutathione as a therapeutic 
strategy in Alzheimer’s disease. Drug Dev Res, 2002. 56: p. 428–437. 
44.  Padurariu, M., A. Ciobica, L. Hritcu, B. Stoica, W. Bild, and C. Stefanescu, Changes of 
some oxidative stress markers in the serum of patients with mild cognitive impairment 
and Alzheimer’s disease. Neurosci Lett, 2010. 469: p. 6-10. 
45.  Nakaki, T., and T. Fujii, Nitration modifying function of proteins, hormones and 
neurotransmitters. Jpn J Pharmocol, 1999. 79: p. 125-129. 
46.  Pacher, P., J.S. Beckman, and L. Liaudet, Nitric oxide and peroxynitrite in health and 
disease. Physiol Rev, 2007. 87: p. 315-424.   
47.  Bosch-Morell, F., L. Floh’e, N. Mar´in, and F.J. Romero, 4-Hydroxynoneal inhibits 
glutathione peroxidase:  protection by glutathione. Free Radic Biol Med, 1999. 26(11-
12): p. 1383-1387.  
 
42 
48.  Esterbauer, H., R.J. Schaur, and H. Zollner, Chemistry and biochemistry of                       
4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med,  1991. 
11(1): p. 81-128.   
49.  Lang, C.A., B.J. Mills, W. Mastropaolo, and M.C. Liu, Blood glutathione decreases in 
chronic diseases. J Lab Clin Med, 2000. 135: p. 402-405.   
50.  The Washington Times.  Washington Associated Pres, U.S. wants effective Alzheimer’s 
treatment by 2025. 2012  January 20, 2012]; Available from:    
http://www.washingtontimes.com/news/2012/jan/17/us-wants-effective-
alzheimers-treatment-2025/.   
51.  Subar, A.F., F.E. Thompson, V. Kipnis, et al., Comparative validation of the Block, 
Willett, and National Cancer Institute food frequency questionnaires : the Eating at 
America's Table Study. Am J Epidemiol, 2001. 154(12): p. 1089-1099.  
52.  Block, G., A.M. Hartman, C.M. Dresser, et al., A data-based approach to diet 
 questionnaire design and testing.  Am J Epidemiol, 1986. 124: p. 453-469.   
53.  Block, G., L.M. Coyle, A.M. Hartman, et al., Revision of dietary analysis software for the 
 health habits and history questionnaire.  Am J Epidemiol, 1994. 139: p. 1190-1196. 
54.  Mares-Perlman, J.A., B.K. Klein, R. Klein, et al., A diet history questionnaire ranks  
 nutrient intakes in middle-aged and older men and women similarly to multiple food 
 records. J Nutr, 1993. 123: p. 489-501.   
55.  Block, G., M. Woods, A. Potosky, et al., Validation of a self-administered diet history 
 questionnaire using multiple diet records. J Clin Epidemiol, 1990. 46: p. 1327-1335. 
 
43 
56.  Nutrition Quest.  Our Research:  Questionnaires.  Development and Validation of 
 Block FFQs and Screeners.  2012 June 25, 2012; Available from:  
 http://nutritionquest.com/company/our-research-questionnaires/ 
57. Thompson, J.L., M.M. Manore, and L.A. Vaughan, The science of nutrition.  San 
 Francisco, CA: Pearson Benjamin Cummings, 2008: p. 801. 
58. Thompson, J.L., M.M. Manore, and L.A. Vaughan, The science of nutrition.  San 
 Francisco, CA: Pearson Benjamin Cummings, 2008: p. 324-325. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
44 
APPENDIX A 
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Fig. 1. Glutathione (GSH)-dependent protection against oxidative stress. GSH is a major antioxidant 
in the brain, which non-enzymatically reacts with superoxide, nitric oxide, hydroxyl radical, and 
peroxynitrite (dotted arrow). GSH also reacts with H2O2 or other peroxides catalyzed by GPx/CAT. 
Abbreviations are as follows: O2−:superoxide, H2O2: hydrogen peroxide, GPx: glutathione peroxidase, 
CAT: catalase, NO: nitric oxide, ONOO−: peroxynitrite, HO⋅:hydroxyl radical (1). 
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APPENDIX B 
 
 
 Fig. 1. Homeostasis of glutathione is maintained intracellularly through a de novo and 
salvage synthesis pathway.  Tight regulation of the GSH:GSSG ratio is maintained by 
glutathione reductase (14).  
  
Reference (14)  
  
